Graham Capital Management, L.P. Maxcyte, Inc. Transaction History
Graham Capital Management, L.P.
- $4.38 Billion
- Q1 2025
A detailed history of Graham Capital Management, L.P. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 36,726 shares of MXCT stock, worth $46,642. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,726
Previous 23,047
59.35%
Holding current value
$46,642
Previous $95,000
5.26%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
68MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$12.7 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$10.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$8.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$7.11 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$6.41 Million11.05% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $129M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...